‘What is already known’
-Development of chronic fibrosis is critical in the progression of cirrhosis and its associated complications in many hepatic disorders. -Myofibroblasts are the main pathological players in liver fibrogenic responses and urges the identification of factors that regulate their activation. -Cortistatin is a potent anti-inflammatory neuropeptide that downregulates acute fibrosis in lung.